Leucovorin Calcium Market Players:
- Exelixis Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- PromoCell GmbH
- Thermo Fisher Scientific Inc.
- Boehringer Ingelheim GmbH
- Bayer AG
- Abbott Laboratories
- Merck & Co., Inc.
- Mylan N.V.
- Novartis International AG
- Pfizer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of leucovorin calcium is evaluated at USD 39.36 million.
The global leucovorin calcium market size exceeded USD 34.38 million in 2025 and is set to expand at a CAGR of over 16.1%, surpassing USD 152.98 million revenue by 2035.
By 2035, North America is expected to secure the largest share of the leucovorin calcium market, bolstered by strong pharmaceutical presence and elevated healthcare spending owing to advanced healthcare infrastructure.
Key players in the market include Exelixis Inc., PromoCell GmbH, Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Abbott Laboratories, Merck & Co., Inc., Mylan N.V., Novartis International AG, Pfizer Inc.
